Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 16:39:05 25/07/2024 BST 5-day change 1st Jan Change
155.00 EUR 0.00% Intraday chart for Merck KGaA +1.67% +7.63%

This article is for Premium subscribers only

Signed up already?

Log In

Not subscribed yet?

Subscribe

The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.

Germany's Merck to Sell Surface Solutions Unit For $721 Million DJ
Merck KGaA to Sell Surface Solutions Unit for EUR665 Million MT
Merck KGaA to Divest Surface Solutions Segment for EUR665 Million MT
MERCK : xevinapant’s nasty scratch Alphavalue
MERCK KGAA : Gets a Buy rating from Barclays ZD
MERCK KGAA : Receives a Buy rating from Barclays ZD
Merck KGaA Secures Spot in German Supply Chain Digitalization Project MT
MERCK : Q2 cost absorption and the most recent cool development Alphavalue
German Stocks in Red as ECB Delivers Rate Hold MT
MERCK KGAA : Gets a Buy rating from Jefferies ZD
Merck KGaA to Buy French Semiconductor Metrology Group Unity-SC MT
JPMorgan rates Merck KGaA at 'Overweight' - Target 190 euros DP
Germany's Merck to Buy Unity-SC for at Least $170 Million DJ
MERCK KGAA : JP Morgan reaffirms its Buy rating ZD
Merck acquires French company Unity-SC for 155 million euros RE
MERCK KGAA : Receives a Buy rating from Jefferies ZD
Merck KGaA: share price down, analyst lowers target CF
MERCK KGAA : UBS lowers price target CF
UBS lowers target for Merck KGaA to 178 euros - 'Buy' DP
MERCK KGAA : UBS keeps its Buy rating ZD
Dawn Health and Merck Collaborate to Support Growth Disorders Care CI
Chemicals collective agreement: Bonus days for union members DP
Chemicals collective bargaining agreement: extra day for trade unionists DP
Chemical industry wage partners seek solution before the end of the peace period DP
German Stocks Fall Tuesday DJ
Chart Merck KGaA
More charts
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Employees
62,345
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
155.00EUR
Average target price
180.81EUR
Spread / Average Target
+16.65%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck KGaA
  5. Merck KGaA : A European big pharma with positive momentum